Washington | Hillary Clinton has released new information about her health as she recuperated from a diagnosis of “mild, non-contagious” pneumonia, with her doctor stressing she remains healthy overall and “fit to serve” as president.
Pressure had mounted for the campaign to release information about the Democratic White House nominee’s medical status after she fell ill at a 9/11 memorial event Sunday, and it was disclosed that she had pneumonia.
The former secretary of state, 68, “continues to remain healthy and fit to serve as president of the United States,” her personal physician Lisa Bardack wrote in a detailed, two-page “summary update” on Clinton’s health.
Bardack released Clinton’s laboratory results that showed “normal” readings for cholesterol, triglycerides and other key readings.
“The remainder of her complete physical exam was normal and she is in excellent mental condition,” she said.
Bardack also said Clinton has been taking the anti-coagulant Coumadin, and that her blood levels “have been relatively stable.”
Clinton “is recovering well with antibiotics and rest” from her bout with pneumonia, she added.
Clinton had released a detailed statement about her medical history in July 2015.
Her campaign had been pressed to be more transparent about Clinton’s health, particularly after it failed to reveal her Friday pneumonia diagnosis until Sunday, when she nearly collapsed as she left the Ground Zero site in New York.
Her rival Donald Trump is also being called on to reveal his own medical records, something he has not done save for a brief letter released last year by Harold Bornstein, the Republican nominee’s doctor for 35 years, who wrote that Trump’s health was “excellent and that a recent examination “showed only positive results.”
Trump had another physical in recent days, and he went on the television set of celebrity doctor Mehmet Oz on Wednesday to disclose his new health records.
In a statement, the show said “Dr Oz took Mr Trump through a full review of systems.” The show airs Thursday.
Subscribe to our email newsletter.